It is additionally accredited for Grownups who will be overweight with a number of bodyweight-associated situations, including large blood pressure or Type two diabetic issues (significant blood sugar). In March of 2024, the FDA approved an extra sign for Wegovy—to lower the risk of cardiovascular death, heart attack, and stroke https://glp-1weightlossmed.com/product/wegovy/